Regeneron Pharmaceuticals Inc. logo

Regeneron Pharmaceuticals Inc.

REGN | NASDAQ
Chart Builder DCF Calculator
$961.26
+$33.37 (+3.60%)
At close: Nov 2, 2026, 4:00 PM ET
$920.00
-$7.89 (-0.85%)
Pre-market: Nov 2, 2026, 9:27 AM ET
Fiscal Quarter
Period Ending
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
Cash & Equivalents
3.66B 2.46B 2.96B 3.12B 2.51B 2B 3.09B 2.49B 2.01B 1.92B 2.6B 2.73B 2.15B 1.94B 3.92B 3.11B 3.49B 3.4B 3.35B 2.89B 3.43B 2.07B 1.44B
Short-Term Investments
5.64B 5.54B 5.79B 5.49B 5.94B 5.47B 5.26B 6.52B 7.78B 7.89B 7.92B 8.11B 7.76B 6.99B 5.04B 4.64B 3.53B 4.17B 3.7B 2.81B 2.36B 1.84B 2.07B
Long-Term Investments
9.56B 9.83B 9.79B 10.26B 10.29B 10.06B 9.28B 8.9B 8.49B 7.72B 6.98B 5.4B 5.78B 6.33B 6.07B 6.59B 5.97B 6.42B 7.08B 6.84B 5.63B 3.9B 3.54B
Other Long-Term Assets
2.47B 2.31B 2.13B 1.82B 1.67B 1.54B 1.39B 1.14B 1.04B 993.8M 470.2M 444.1M 409.9M 393.2M 349.6M 336.4M 320.2M 269.9M 262M 216.1M 145.9M 142.9M 145.7M
Receivables
7.58B 6.57B 5.73B 5.74B 5.69B 5.61B 5.56B 6.21B 6.11B 5.72B 5.22B 5.67B 5.58B 5.12B 5.12B 5.33B 5.55B 5.16B 4.84B 6.04B 5.45B 7B 4.17B
Inventory
2.89B 3.08B 3.1B 3.2B 3.25B 3.21B 3.19B 3.09B 3.02B 2.87B 2.71B 2.58B 2.56B 2.51B 2.42B 2.4B 2.41B 2.22B 1.99B 1.95B 2.05B 1.98B 2.16B
Other Current Assets
n/a n/a n/a 474.8M 595.6M 574.3M 468.9M 349.2M 412M 681.9M 414.9M 386.6M 574.7M 366.3M 406.2M n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
20.8B 18.45B 18.21B 18.02B 17.98B 16.86B 17.57B 18.66B 19.33B 19.08B 18.87B 19.48B 18.63B 16.92B 16.91B 15.88B 15.43B 15.53B 14.31B 14.01B 13.78B 13.34B 10.06B
Property-Plant & Equipment
5.73B 5.46B 5.27B 5.12B 5B 4.84B 4.69B 4.6B 4.44B 4.31B 4.23B 4.15B 4.01B 3.92B 3.88B 3.76B 3.7B 3.64B 3.56B 3.48B 3.4B 3.36B 3.26B
Goodwill & Intangibles
1.32B 1.31B 1.29B 1.26B 1.38B 1.35B 1.17B 1.15B 1.12B 1.1B 1.06B 1.04B 1.02B 953M 928.7M 915.5M 804.1M n/a n/a 6.7M n/a n/a n/a
Total Long-Term Assets
23.61B 23.28B 22.66B 22.54B 22.19B 21.36B 19.97B 19.1B 18.11B 17.01B 15.5B 13.6B 13.53B 13.73B 13.15B 13.33B 12.25B 11.68B 12.04B 11.42B 9.9B 8.15B 7.72B
Total Assets
44.41B 41.73B 40.87B 40.56B 40.17B 38.22B 37.55B 37.76B 37.44B 36.09B 34.37B 33.08B 32.16B 30.66B 30.06B 29.21B 27.68B 27.21B 26.35B 25.43B 23.67B 21.49B 17.77B
Account Payables
1.14B 1.16B 1.03B 939M 903.8M 723.9M 705.5M 789.5M 497.3M 561.7M 671.3M 606.6M 536.6M 547.3M 599.5M 589.2M 535.6M 534.2M 470.3M 564M 427M 476M 542.9M
Deferred Revenue
749.8M 220.4M 636.2M 553M 545.6M 481.9M 619.3M 627.7M 627.2M 586M 516.7M 458.9M 417.3M 381.1M 426.3M 477.9M 547.2M 566.3M 491.3M 442M 507.8M 520M 464.9M
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
n/a 1.18B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Liabilities
6.2B 5.53B 5.11B 4.37B 4.43B 3.67B 3.57B 3.94B 3.66B 3.51B 3.58B 3.42B 3.6B 3.1B 3.1B 3.14B 2.88B 3.03B 3.01B 3.93B 3.71B 3.73B 3.22B
Long-Term Debt
1.99B 1.99B 1.99B 1.99B 1.99B 1.99B 1.98B 1.98B 1.98B 1.98B 1.98B 1.98B 1.98B 1.98B 1.98B 1.98B 1.98B 1.98B 1.98B 1.98B 1.98B 1.98B 1.98B
Other Long-Term Liabilities
2.5B 2.5B 2.13B 2.02B 1.86B 1.7B 1.67B 1.57B 1.54B 1.46B 908.5M 854.1M 832.4M 716.8M 677.3M 638M 598.6M 724.7M 692.5M 680.2M 662.6M 596.3M 571.5M
Total Long-Term Liabilities
4.7B 4.49B 4.34B 4.93B 4.79B 4.61B 4.59B 4.46B 4.46B 4.37B 3.8B 3.68B 3.66B 3.54B 3.46B 3.41B 3.36B 3.48B 3.43B 2.73B 2.7B 2.63B 2.58B
Total Liabilities
10.91B 10.02B 9.45B 9.3B 9.21B 8.28B 8.16B 8.41B 8.12B 7.88B 7.38B 7.11B 7.26B 6.64B 6.56B 6.55B 6.24B 6.52B 6.43B 6.67B 6.41B 6.36B 5.8B
Total Debt
2.71B 1.99B 2.71B 2.71B 2.71B 2.71B 2.7B 2.7B 2.7B 2.7B 2.7B 2.7B 2.7B 2.7B 2.7B 2.7B 2.7B 2.7B 2.7B 2.7B 2.7B 2.7B 2.7B
Book Value
33.5B 31.71B 31.42B 31.26B 30.96B 29.94B 29.39B 29.35B 29.33B 28.21B 26.99B 25.97B 24.9B 24.02B 23.5B 22.66B 21.44B 20.69B 19.91B 18.77B 17.26B 15.13B 11.98B
Book Value Per Share
317.22 296.92 291.77 290.76 288.79 275.68 264.28 257.94 252.37 244.42 234.50 228.23 219.62 210.87 206.10 198.81 190.06 181.47 176.08 165.80 151.52 136.53 108.36
Common Stock
100K n/a 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K 100K
Retained Earnings
39.47B 37.62B 36.42B 35.8B 35.05B 33.68B 32.38B 31.67B 30.76B 29.41B 27.98B 27.26B 26.1B 25.09B 24.12B 23.31B 22.11B 20.79B 19.94B 18.97B 16.74B 15.11B 12.01B
Comprehensive Income
-197.5M -35.8M 11.9M 77.5M 69M 52.5M 29.1M -7.9M 60.2M -69.9M -77.2M -80.9M -176.8M -197.7M -181.6M -238.8M -275.1M -223.8M -170.1M -26.2M 9.5M 15.7M 16.2M
Shareholders Equity
33.5B 31.71B 31.42B 31.26B 30.96B 29.94B 29.39B 29.35B 29.33B 28.21B 26.99B 25.97B 24.9B 24.02B 23.5B 22.66B 21.44B 20.69B 19.91B 18.77B 17.26B 15.13B 11.98B
Total Investments
15.2B 15.37B 15.58B 15.75B 16.22B 15.53B 14.54B 15.42B 16.28B 15.61B 14.9B 13.51B 13.54B 13.32B 11.11B 11.23B 9.5B 10.59B 10.79B 9.65B 7.99B 5.74B 5.61B

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.